Home › Plaveiselcelcarcinoom van hoofd en hals › Virginia › Arlington
Plaveiselcelcarcinoom van hoofd en hals klinische studies in Arlington, VA
26 studies voor Plaveiselcelcarcinoom van hoofd en hals zoeken deelnemers op locaties in en rond Arlington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruterenFase 1
- Site 04, Fairfax · 11 mijl verwijderd
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RekruterenFase 1
- ALX Center 2, Fairfax · 11 mijl verwijderd
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RekruterenFase 3
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruterenFase 2
- Inova Fairfax Hospital, Falls Church · 4 mijl verwijderd
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- Inova Fair Oaks Hospital, Fairfax · 11 mijl verwijderd
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- NEXT Oncology, Fairfax · 11 mijl verwijderd
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RekruterenFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site, Fairfax · 11 mijl verwijderd
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruterenFase 1
- Normunity Investigational Site, Fairfax · 11 mijl verwijderd
A Study of DM005 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- NEXT, Fairfax · 11 mijl verwijderd
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruterenFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mijl verwijderd
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruterenFase 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mijl verwijderd
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Fairfax · 11 mijl verwijderd
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
RekruterenFase 1
- NEXT Oncology, Fairfax · 11 mijl verwijderd
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site 102, Fairfax · 11 mijl verwijderd
- Research Site 112, Fairfax · 11 mijl verwijderd
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Plaveiselcelcarcinoom van hoofd en hals studies in andere steden
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Philadelphia, PA26 studies
- Chicago, IL26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- New Haven, CT22 studies
- Pittsburgh, PA22 studies
Andere studies in Arlington
- Niet-kleincellige longkanker104 studies
- Metastatische kanker53 studies
- Colorectale kanker52 studies
- Kanker (alle vormen)48 studies
- Borstkanker47 studies
- Eierstokkanker46 studies
- Longkanker41 studies
- Endometriumkanker39 studies
- Aldermeesklierkanker33 studies
- Kleincellige longkanker23 studies
- Maagkanker20 studies
- Drievoudig negatieve borstkanker20 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.